Skip to main content

Table 1 Baseline Clinic features according to glycometabolism diagnosis by OGTT

From: Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China

Clinic features Diabetes mellitus (n = 1220) Prediabetes (n = 777) Normoglycemia (n = 910) P
Age, y (median, Q1–3) 64 (55, 73) 61 (52,72) 58 (49, 69)) <0.001
Male, n (%) 711(58.3) 501 (64.5%) 616 (67.7) <0.001
Tobacco use, n (%)     0.036
 Never 712 (58.4) 428 (55.1) 480 (52.7)  
 Quit 110 (9.0) 74 (9.5) 79 (8.7)  
 Current 351 (28.8) 246 (31.7) 320 (35.2)  
Alcohol consumption, n (%)     0.164
 Mild 213 (17.5) 132 (17.0) 171 (18.8)  
 Moderate to severe 165 (13.5) 131 (16.9) 152 (16.7)  
 Never 817 (67.0) 494 (63.6) 564 (62.0)  
BMI, kg/m2 (median, Q1–3) 25.0 (22.9,27.3) 24.5 (22.5,26.8) 24.2 (22.0,26.2) <0.001
NIHSS (median,Q1-Q3) 5 (2–9) 5 (2,9) 4 (2–8) 0.002
Creatinine,m mol L−1 (median, Q1–3) 71.2 (58.0, 87.0) 72.0 (60.0, 87.0) 71.8 (59.9, 86.7) 0.425
LDL, m mol L−1 (median, Q1–3) 3.0 (2.4, 3.6) 2.9 (2.3, 3.5) 2.8 (2.3, 3.4) 0.001
HDL,m mol L−1(median, Q1–3) 1.1(1.0, 1.3) 1.2 (1.0, 1.4) 1.2 (1.1, 1.4) <0.001
Systolic blood pressure, mmHg (median, Q1–3) 150 (138, 160) 143 (130, 160) 146 (130, 160) <0.001
Homocysteine, μ mol L−1, (median, Q1–3) 14.4 (11.5, 18.7) 15.5 (12.0, 21.9) 15.7 (12.3, 22.8) <0.001
HOMA2-IR (median, Q1–3) 2.5 (1.6, 4.0) 1.9 (1.1, 3.0) 1.6 (0.9, 2.5) <0.001
Past medical history, yes, n (%)     
 Coronary artery disease 172 (14.1) 87 (11.2) 90 (9.9) 0.009
 Hypertension 795 (65.2) 470 (60.5) 514 (56.5) <0.001
 Atrial fibrillation 66 (5.4) 54 (6.9) 31 (3.4) 0.006
Stroke types, n (%)     <0.001
 IS 1015 (83.2) 541 (69.6) 675 (74.2)  
 ICH 174 (14.3) 185 (23.8) 198 (21.8)  
 SAH 31 (2.5) 51 (6.6) 37 (4.1)  
  1. OGTT the oral glucose tolerance test, BMI body mass index, LDL low density lipoprotein, HDL high density lipoprotein, NIHSS the National Institutes of Health Stroke Scale, HOMA2-IR the correctly solved computer model for homeostasis model assessment of insulin resistance, IS ischemic stroke, ICH intra-cerebral hemorrhage, SAH subarachnoid hemorrhage